Our data also demonstrated that the inhibition of AKT activity can enhance the upregulation of Bax expression and downregulation of Bcl-2 expression induced by baicalein, suggesting that AKT may be at the upstream of the baicalein-induced apoptosis of prostate cancer cells. This evidence concerns the gene BAX and prostate carcinoma.